Effectiveness and safety of protease inhibitors for the hepatitis C treatment in a hospital of South Brazil: real life data

• Autores principales: Aline Bianca Borba Mattana (Autor), Karin Hepp Schwambach (Autor), Alberi Adolfo Feltrin (Autor), Mareni Rocha Farias (Autor), Carine Raquel Blatt (Autor)
• Formato: Libro
• Publicado: São Paulo State University (UNESP), 2020-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Introduction: The combination of Inhibitors of protease boceprevir (BOC) or telaprevir (TLV) concomitantly with peginterferon (PEG) and ribavirin (RBV) constitute the triple therapy (TT) for Hepatitis C treatment. Objective: To describe the experience of the TT treatment of chronic hepatitis C patie...